AzTrials
AzTrials

Exercise Training AdaptationHIIT-KICKNCT07449663

SPORT-SPECIFIC HIIT IN ELITE KICKBOXERS

A study testing Sport-Specific High-Intensity Interval Training and Regular Training in people with Exercise Training Adaptation and Exercise Physiology, run by Adiyaman University at 1 site in Turkey (Türkiye).

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

This study examines how sport-specific high-intensity interval training (HIIT) affects the body in elite kickboxers. Participants are randomly assigned to either a HIIT training group or a control group. Read more about this study

Who is it for?
Ages 18 to 30 years, men onlyHealthy volunteers can take part
What is being tested?
Sport-Specific High-Intensity Interval Training and Regular Training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteTurkey (Türkiye)
Study dates
15 Jan 2026to 15 Mar 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Male elite kickboxers aged 18 to 30 years
  • At least five years of regular kickboxing training experience
  • Active participation in kickboxing training
  • Ability to complete the training program

Who cannot join

  • Serious injury within the previous six months
  • Presence of chronic or cardiometabolic disease
  • Regular use of medications or ergogenic supplements
  • Tobacco or alcohol use
  • Inability to complete the training program

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Adiyaman University Faculty of Sport Sciences

    Adıyaman, 02040

Other trials in Turkey (Türkiye)

About this study

Official title: SPORT-SPECIFIC HIGH-INTENSITY INTERVAL TRAINING INDUCES SELECTIVE APELIN AND IRISIN RESPONSES IN ELITE KICKBOXERS: A RANDOMIZED CONTROLLED TRIAL

This study examines how sport-specific high-intensity interval training (HIIT) affects the body in elite kickboxers.

Participants are randomly assigned to either a HIIT training group or a control group. The HIIT group performs supervised sport-specific training for eight weeks, while the control group continues their usual training. Blood samples are collected before and after the training period.

Read more

The main goal of this study is to determine whether HIIT changes levels of exercise-related proteins such as apelin and irisin. These proteins may reflect how the body adapts to intense training.

The findings may help researchers and coaches better understand the effects of high-intensity training and may support the development of safer and more effective training programs for athletes.

Read the detailed description

This randomized controlled trial investigates the effects of sport-specific high-intensity interval training (HIIT) on biochemical markers related to exercise adaptation in elite kickboxers.

High-intensity interval training is widely used in combat sports because it reflects the intermittent high-intensity nature of competition. Exercise-induced proteins such as apelin and irisin are considered potential biomarkers of physiological adaptation to training. However, biochemical responses to sport-specific HIIT in elite combat athletes remain insufficiently understood.

Participants are elite male kickboxers aged 18-30 years with at least five years of training experience. Participants are randomly assigned to either an experimental group performing sport-specific HIIT or a control group continuing their regular training routines.

The HIIT program lasts eight weeks and includes supervised training sessions five days per week at an intensity of approximately 85-95 percent of maximum heart rate. The control group continues their usual technical and tactical kickboxing training without participation in the structured HIIT program.

Blood samples are collected at baseline and after completion of the eight-week intervention period. Serum concentrations of apelin and irisin are assessed as primary outcomes. Secondary outcomes include leptin, interleukin-6, and selected hematological parameters.

The purpose of this study is to evaluate biochemical adaptations to sport-specific HIIT and to identify potential biomarkers of training adaptation in elite athletes. The findings may contribute to improved athlete monitoring and the development of evidence-based training programs.

Being tested
Sport-Specific High-Intensity Interval Training, Regular Training
Keywords
high-intensity interval training, apelin, irisin, kickboxing, myokines, biomarkers

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Sport-Specific High-Intensity Interval TrainingBehavioural

    Participants perform supervised sport-specific high-intensity interval training five days per week for eight weeks. Training intensity is maintained at approximately 85-95 percent of maximum heart rate. The program consists of repeated high-intensity exercise intervals interspersed with active recovery periods and is designed to reflect the physiological demands of competitive kickboxing.

  • Regular TrainingBehavioural

    Participants continue their usual kickboxing training routines without participation in the structured HIIT program.

Study groups in NCT07449663
Study groupRoleWhat they receive
Sport-Specific HIITExperimentalParticipants perform supervised sport-specific high-intensity interval training five days per week for eight weeks at an intensity of approximately 85-95 percent of maximum heart rate.
Receives: Behavioral: Sport-Specific High-Intensity Interval Training
Regular TrainingActive comparatorParticipants continue their regular kickboxing training without participation in the structured HIIT program.
Receives: Behavioral: Regular Training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Serum Apelin Concentration

    Serum apelin concentration measured using enzyme-linked immunosorbent assay (ELISA).

    Measured: Baseline and Week 8

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Mar 2026
  2. Study start15 Jan 2026
  3. Primary completion15 Mar 2026 (estimated)
  4. Study completion15 Mar 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants are randomly assigned to either a sport-specific HIIT group or a control group continuing regular training.
Masking
None (open label)
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07449663
Sponsor's protocol ID
ADIYAMAN-HIIT-RCT-2025
Acronym
HIIT-KICK
Status last verified
Mar 2026
First submitted
27 Feb 2026
Last updated
4 Mar 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared. According to the informed consent form, personal information and study data will be kept confidential and will not be disclosed to third parties without written permission from the participants.

Questions about this trial

What is this clinical trial studying?

A study testing Sport-Specific High-Intensity Interval Training and Regular Training in people with Exercise Training Adaptation and Exercise Physiology, run by Adiyaman University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 4 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Serum Apelin Concentration (time frame: Baseline and Week 8). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Mar 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in